1215010-55-1Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1ClXMBSZPZJLPTFMV-UHFFFAOYSA-Na trypanocidal agent for treating African sleeping sickness; structure in first source
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明DDD85646 is a moderately bioavailable pyrazole sulphonamide inhibitor of T. brucei N-myristoyltransferase (TbNMT) with an apparent Ki value of 1.44 nM. T. brucei is the parasite responsible for human African trypanosomiasis (HAT), also known as African sleeping sickness, and is transmitted through the tsetse fly. DDD85646 administration in mice (12.5 mg/kg for four days) ameliorated T. brucei in an acute mouse model of HAT. It less potently inhibits growth of T. cruzi (EC50 = 6.9 μM).
使用DDD85646 is a potent inhibitor of Trypanosoma brucei N-myristoyltransferase (TbNMT).
現在のフィルター条件では反応記録がありません。
読み込み中…
1215010-55-1DTXSID701347812CHEMBL1230468